The prescription-only S4
drug Clenbuterol, used as a
bronchodilator in horses and
by athletes as a performance
enhancer, is increasingly being used
by the general public.
A study published in the Medical
Journal of Australia found 63
cases of clenbuterol exposures
over nine years of data from the
NSW Poisons Information Centre,
with a “dramatic increase” from
three cases in 2008 to 27 in 2012,
with 84% of patients requiring
hospitalisation.
Researcher Dr Jonathan Brett said
there were arguments to restrict
sales by puting the drug into the
same category as benzodiazepines
and anabolic steroids.The above article was sent to subscribers in Pharmacy Daily's issue from 06 Mar 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Mar 14
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
AUSTRALIA’S public hospitals are facing their lengthiest wait times on record for planned surgeries, with emergency departments struggling under access blockages, according to the latest annual Public Hospital Report Card by the Australian Medical Association (AMA).
THE University of South Australia has released a new study to help healthcare workers better support women with persistent pelvic pain, including symptoms that are suggestive of gynaecological, lower urinary tract, bowel, sexual, and pelvic floor dysfunction.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.